Monocytes in coronary artery disease and atherosclerosis: Where are we now?

Journal of the American College of Cardiology

Volumn 62, Issue 17, 2013, Pages 1541-1551

  Ghattas, Angie ^a,b   Griffiths, Helen R ^b   Devitt, Andrew ^b   Lip, Gregory Y H ^a,b   Shantsila, Eduard ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

atherosclerosis; inflammation; macrophages; monocyte subsets

Indexed keywords

ANGIOPOIETIN RECEPTOR; CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; CD64 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; FRACTALKINE; GELATINASE A; GELATINASE B; HLA DR ANTIGEN; IMMUNOGLOBULIN M; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; L SELECTIN; LYMPHOTOXIN; MATRIX METALLOPROTEINASE 14; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL COLLAGENASE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL METABOLISM; CELL MIGRATION; CELL SUBPOPULATION; CORONARY ARTERY DISEASE; DISEASE COURSE; HEART VENTRICLE REMODELING; HUMAN; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION;

EID: 84886078994     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.07.043     Document Type: Review

References (83)

1. J. Logue, H.M. Murray, and P. Welsh Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation Heart 97 2011 564 568
2. C.C. Kuo, A. Shor, L.A. Campbell, H. Fukushi, D.L. Patton, and J.T. Grayston Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries J Infect Dis 167 1993 841 849
3. J.D. Laman, A.H. Schoneveld, F.L. Moll, M. van Meurs, and G. Pasterkamp Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques Am J Cardiol 90 2002 119 123
4. A.E. Zeituni, J. Carrion, and C.W. Cutler Porphyromonas gingivalis-dendritic cell interactions: consequences for coronary artery disease J Oral Microbiol 2 2010 Dec 21 10.3402/jom.v2i0.5782
5. S.J. Ott, N.E. El Mokhtari, and M. Musfeldt Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease Circulation 113 2006 929 937
6. G. Wick, M. Knoflach, and Q. Xu Autoimmune and inflammatory mechanisms in atherosclerosis Annu Rev Immunol 22 2004 361 403
7. T.A. Pearson, G.A. Mensah, and R.W. Alexander Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
8. P.M. Ridker, N. Rifai, and M. Clearfield Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N Engl J Med 344 2001 1959 1965
9. A.C. van der Wal, A.E. Becker, C.M. van der Loos, and P.K. Das Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology Circulation 89 1994 36 44
10. M.M. Oude Nijhuis, J.K. van Keulen, G. Pasterkamp, P.H. Quax, and D.P. de Kleijn Activation of the innate immune system in atherosclerotic disease Curr Pharm Des 13 2007 983 994
11. B.A. Kottke, and M.T. Subbiah Pathogenesis of atherosclerosis. Concepts based on animal models Mayo Clin Proc 53 1978 35 48
12. J. Shalhoub, M.A. Falck-Hansen, A.H. Davies, and C. Monaco Innate immunity and monocyte-macrophage activation in atherosclerosis J Inflamm (Lond) 8 2011 9
13. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
14. M.P. de Winther, E. Kanters, G. Kraal, and M.H. Hofker Nuclear factor kappaB signaling in atherogenesis Arterioscler Thromb Vasc Biol 25 2005 904 914
15. K.J. Katschke Jr., J.B. Rottman, and J.H. Ruth Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis Arthritis Rheum 44 2001 1022 1032
16. J.S. Duffield Macrophages and immunologic inflammation of the kidney Semin Nephrol 30 2010 234 254
17. R.T. Palframan, S. Jung, and G. Cheng Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues J Exp Med 194 2001 1361 1373
18. F. Geissmann, S. Jung, and D.R. Littman Blood monocytes consist of two principal subsets with distinct migratory properties Immunity 19 2003 71 82
19. M. Nahrendorf, F.K. Swirski, and E. Aikawa The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions J Exp Med 204 2007 3037 3047
20. R.G. Gerrity, H.K. Naito, M. Richardson, and C.J. Schwartz Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages Am J Pathol 95 1979 775 792
21. K.L. Wong, J.J. Tai, and W.C. Wong Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets Blood 118 2011 e16 e31
22. F.K. Swirski, P. Libby, and E. Aikawa Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata J Clin Invest 117 2007 195 205
23. P. Ancuta, R. Rao, and A. Moses Fractalkine preferentially mediates arrest and migration of CD16+ monocytes J Exp Med 197 2003 1701 1707
24. P. Ancuta, J. Wang, and D. Gabuzda CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells J Leukoc Biol 80 2006 1156 1164
25. N. Saederup, L. Chan, S.A. Lira, and I.F. Charo Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis Circulation 117 2008 1642 1648
26. C. Combadiere, S. Potteaux, and M. Rodero Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice Circulation 117 2008 1649 1657
27. C. Auffray, D. Fogg, and M. Garfa Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior Science 317 2007 666 670
28. J. Cros, N. Cagnard, and K. Woollard Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors Immunity 33 2010 375 386
29. E. Shantsila, B. Wrigley, and L. Tapp Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology J Thromb Haemost 9 2011 1056 1066
30. F. Geissmann, M.G. Manz, S. Jung, M.H. Sieweke, M. Merad, and K. Ley Development of monocytes, macrophages, and dendritic cells Science 327 2010 656 661
31. A. Gratchev, I. Sobenin, A. Orekhov, and J. Kzhyshkowska Monocytes as a diagnostic marker of cardiovascular diseases Immunobiology 217 2012 476 482
32. J.E. Feig, J.S. Quick, and E.A. Fisher The role of a murine transplantation model of atherosclerosis regression in drug discovery Curr Opin Investig Drugs 10 2009 232 238
33. J. Llodra, V. Angeli, J. Liu, E. Trogan, E.A. Fisher, and G.J. Randolph Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques Proc Natl Acad Sci U S A 101 2004 11779 11784
34. J.E. Feig, Y. Shang, and N. Rotllan Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages PLoS One 6 2011 e28534
35. J.S. Alpert, K. Thygesen, E. Antman, and J.P. Bassand Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction J Am Coll Cardiol 36 2000 959 969
36. J.C.E. Underwood, and S.S. Cross General and Systematic Pathology 5th edition 2009 Churchill Livingstone London
37. R.E. O'Connor, L. Bossaert, and H.R. Arntz Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Circulation 122 2010 S422 S465
38. H.L. Chughtai, M. Janjua, F. Matta, F. Jaweesh, and P.D. Stein Predictors of in-hospital mortality in patients receiving thrombolytic therapy for pulmonary embolism Clin Appl Thromb Hemost 17 2011 656 658
39. Z.S. Galis, G.K. Sukhova, M.W. Lark, and P. Libby Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
40. A.C. Newby, S.J. George, Y. Ismail, J.L. Johnson, G.B. Sala-Newby, and A.C. Thomas Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes Thromb Haemost 101 2009 1006 1011
41. H.J. Medbury, S.L. Tarran, and A.K. Guiffre Monocytes contribute to the atherosclerotic cap by transformation into fibrocytes Int Angiol 27 2008 114 123
42. A.C. Newby Metalloproteinases and vulnerable atherosclerotic plaques Trends Cardiovasc Med 17 2007 253 258
43. Y. Momiyama, R. Ohmori, and N. Tanaka High plasma levels of matrix metalloproteinase-8 in patients with unstable angina Atherosclerosis 209 2010 206 210
44. D.C. Altieri, J.H. Morrissey, and T.S. Edgington Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade Proc Natl Acad Sci U S A 85 1988 7462 7466
45. L.D. Tapp, E. Shantsila, B.J. Wrigley, B. Pamukcu, and G.Y. Lip The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction J Thromb Haemost 10 2012 1231 1241
46. M.M. Aleman, C. Gardiner, P. Harrison, and A.S. Wolberg Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability J Thromb Haemost 9 2011 2251 2261
47. J.M. Lambert, E.F. Lopez, and M.L. Lindsey Macrophage roles following myocardial infarction Int J Cardiol 130 2008 147 158
48. N.G. Frangogiannis, L.H. Mendoza, and G. Ren MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype Am J Physiol Heart Circ Physiol 285 2003 H483 H492
49. N.R. Madamanchi, and M.S. Runge Mitochondrial dysfunction in atherosclerosis Circ Res 100 2007 460 473
50. M. Zhang, and M.C. Carroll Natural antibody mediated innate autoimmune response Mol Immunol 44 2007 103 110
51. D.G. Haegert Phagocytic peripheral blood monocytes from rabbits and humans express membrane receptors specific for IgM molecules: evidence that incubation with neuraminidase exposes cryptic IgM (Fc) receptors Clin Exp Immunol 35 1979 484 490
52. A.J. Singer, and R.A. Clark Cutaneous wound healing N Engl J Med 341 1999 738 746
53. F. Leuschner, P.J. Rauch, and T. Ueno Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis J Exp Med 209 2012 123 137
54. D. Fukui, H. Yasukawa, and Y. Sugi Transient reduction and activation of circulating dendritic cells in patients with acute myocardial infarction Int J Cardiol 160 2012 216 219
55. D. Kretzschmar, S. Betge, and A. Windisch Recruitment of circulating dendritic cell precursors into the infarcted myocardium and pro-inflammatory response in acute myocardial infarction Clin Sci (Lond) 123 2012 387 398
56. D.J. Grieve, J.A. Byrne, A.C. Cave, and A.M. Shah Role of oxidative stress in cardiac remodelling after myocardial infarction Heart Lung Circ 13 2004 132 138
57. S. Jonsson, A. Lundberg, H. Kalvegren, I. Bergstrom, A. Szymanowski, and L. Jonasson Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris PLoS One 6 2011 e19340
58. S. Apostolakis, G.Y. Lip, and E. Shantsila Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovasc Res 85 2010 649 660
59. M. Bouchentouf, P. Paradis, and K.A. Forner Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarction Cell Transplant 19 2010 369 386
60. P. Panizzi, F.K. Swirski, and J.L. Figueiredo Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis J Am Coll Cardiol 55 2010 1629 1638
61. M.J. van Amerongen, M.C. Harmsen, N. van Rooijen, A.H. Petersen, and M.J. van Luyn Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice Am J Pathol 170 2007 818 829
62. A. Anzai, T. Anzai, and S. Nagai Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling Circulation 125 2012 1234 1245
63. E. Shantsila, A. Devitt, and G.Y. Lip Circulating monocytes and atherogenesis: from animal experiments to human studies Thromb Haemost 104 2010 191 193
64. H. Tsujioka, T. Imanishi, and H. Ikejima Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction J Am Coll Cardiol 54 2009 130 138
65. K.S. Rogacev, B. Cremers, and A.M. Zawada CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography J Am Coll Cardiol 60 2012 1512 1520
66. X. Urra, N. Villamor, and S. Amaro Monocyte subtypes predict clinical course and prognosis in human stroke J Cereb Blood Flow Metab 29 2009 994 1002
67. K.S. Rogacev, S. Seiler, and A.M. Zawada CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease Eur Heart J 32 2011 84 92
68. G.H. Heine, C. Ulrich, and E. Seibert CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients Kidney Int 73 2008 622 629
69. E. Shantsila, L.D. Tapp, B.J. Wrigley, S. Montoro-Garcia, and G.Y. Lip CXCR4 positive and angiogenic monocytes in myocardial infarction Thromb Haemost 109 2013 255 262
70. A.M. Zawada, K.S. Rogacev, and B. Rotter SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset Blood 118 2011 e50 e61
71. A.M. van der Laan, A. Hirsch, and L.F. Robbers A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction Am Heart J 163 2012 57 65.e2
72. V. Dayan, G. Yannarelli, and F. Billia Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction Basic Res Cardiol 106 2011 1299 1310
73. M. Kuwana, Y. Okazaki, and H. Kodama Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation J Leukoc Biol 74 2003 833 845
74. M. Salama, O. Andrukhova, S. Roedler, A. Zuckermann, G. Laufer, and S. Aharinejad Association of CD14+ monocyte-derived progenitor cells with cardiac allograft vasculopathy J Thorac Cardiovasc Surg 142 2011 1246 1253
75. C.A. Bush, W. Renner, and H. Boudoulas Corticosteroids in acute myocardial infarction Angiology 31 1980 710 714
76. R.W. Peters, A. Norman, W.W. Parmley, B.B. Emilson, M.M. Scheinman, and M. Cheitlin Effect of therapy with methylprednisolone on the size of myocardial infarcts in man Chest 73 1978 483 488
77. J. Leor, L. Rozen, and A. Zuloff-Shani Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart Circulation 114 2006 I94 100
78. M. Yousef, C.M. Schannwell, M. Kostering, T. Zeus, M. Brehm, and B.E. Strauer The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction J Am Coll Cardiol 53 2009 2262 2269
79. V. Schachinger, S. Erbs, and A. Elsasser Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial Eur Heart J 27 2006 2775 2783
80. G.P. Meyer, K.C. Wollert, and J. Lotz Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial Eur Heart J 30 2009 2978 2984
81. S. Janssens, C. Dubois, and J. Bogaert Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial Lancet 367 2006 113 121
82. J.O. Beitnes, E. Hopp, and K. Lunde Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study Heart 95 2009 1983 1989
83. J.H. Traverse, D.H. McKenna, and K. Harvey Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction Am Heart J 160 2010 428 434